Breast cancer|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Breast cancer

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: May 05, 2017

---

• Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas  
  D Huo et al, JAMA Oncology, May 2017
• Can Men Get Breast Cancer? Yes, they can. Here's what to know.  
  J Abraham, US News, April 27, 2017
• Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.  
  Buchanan Adam H et al. Journal of genetic counseling 2017 Feb 26(1) 79-92
• An exploratory study of patients' views about being at high-risk for breast cancer and risk management beliefs and intentions, before and after risk counselling: Preliminary evidence of the influence of beliefs on post-counselling prevention intentions.  
  Paquet Lise et al. Patient education and counseling 2017 Mar 100(3) 575-582
• Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.  
  Elrick Ashley et al. Journal of genetic counseling 2017 Feb 26(1) 173-181
• Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?  
  Tesson Stephanie et al. Breast (Edinburgh, Scotland) 2017 Feb 31233-240
• When to Tell Daughters About a Genetic Breast Cancer Risk  
  JW Harris, NY Times, April 20, 2017
• A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.  
  Eccleston Anthony et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 567-576
• A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.  
  Li Yonghong et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 547-555
• Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).  
  Pestalozzi Bernhard C et al. BMC cancer 2017 Apr 17(1) 265
• An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.  
  Felts Jesse L et al. The breast journal 2017 Jan
• An exploration of Australian psychologists' role in assessing women considering risk-reducing or contralateral prophylactic mastectomy.  
  Braude Lucy et al. Breast (Edinburgh, Scotland) 2017 Apr 32105-111
• Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.  
  Couch Fergus J et al. JAMA oncology 2017 Apr
• Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.  
  Carmichael Harris et al. Breast cancer research and treatment 2017 Apr 162(2) 225-230
• Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients.  
  Park Boyoung et al. Breast cancer research and treatment 2017 May 163(1) 139-150
• Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.  
  Kurian Allison W et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Apr JCO2016716480

more